GREPPI, MARCO
 Distribuzione geografica
Continente #
EU - Europa 1.858
Totale 1.858
Nazione #
IT - Italia 1.858
Totale 1.858
Città #
Genova 1.130
Genoa 392
Rapallo 299
Vado Ligure 25
Bordighera 12
Totale 1.858
Nome #
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 148
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 147
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 120
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells 112
Harnessing NK Cells for Cancer Treatment 112
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 108
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 105
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer 87
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 77
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 74
New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR- 146a-5p in the regulation of KIR expression 73
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes 65
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 62
New Insights into Endometrial Cancer 59
Expression, role and regulation of NK cell immune checkpoints (PD-1, KIRs, NKG2A) in Ovarian Cancer 59
miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy 58
Case Report: A Peculiar Case of Inflammatory Colitis After SARS-CoV-2 Infection 56
The PD-1 immune checkpoint on human NK cells in normal and pathological condition 52
NK Cell-Based Immunotherapy in Colorectal Cancer 50
Histopathological And Immunohistochemical Prognostic Factors In High-Grade Non-Endometrioid Carcinomas Of The Endometrium (Hg-Necs). Is It Possible To Identify Sub-Groups At Increased Risk? 50
Role of the main non HLA-specific activating NK receptors in pancreatic, colorectal and gastric tumors surveillance 47
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 45
Harnessing Immune Response in Acute Myeloid Leukemia 33
The PD-1 immune checkpoint on human NK cells in normal and pathological condition 33
Relevant role for PD-1 immune checkpoint expressed on NK cells derived from ovarian cancer patients 31
Relevant role for PD-1 immune checkpoint expressed on NK cells derived from ovarian cancer patients 24
Case report: Variable response to immunotherapy in ovarian cancer: Our experience within the current state of the art 19
Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1 18
A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans 18
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers 13
A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans 3
Tumor-Infiltrating Natural Killer Cells 1
Totale 1.959
Categoria #
all - tutte 7.356
article - articoli 5.962
book - libri 0
conference - conferenze 894
curatela - curatele 0
other - altro 281
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.493


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020435 0 7 8 26 42 62 76 33 49 70 52 10
2020/2021308 18 12 20 12 3 71 3 15 30 52 37 35
2021/2022298 9 9 17 23 28 26 16 61 38 27 17 27
2022/2023359 35 32 6 28 57 44 2 28 70 6 42 9
2023/2024349 13 36 9 43 22 35 33 58 16 21 26 37
2024/202544 36 8 0 0 0 0 0 0 0 0 0 0
Totale 1.959